Developing computer-aided detection for lung and colon images has become a priority at Siemens Medical Solutions. The decision is a consequence of Siemens’ -- and other vendors’ -- success in CT.
Developing computer-aided detection for lung and colon images has become a priority at Siemens Medical Solutions. The decision is a consequence of Siemens' - and other vendors' - success in CT.
"We are flooding radiologists with all the images coming off our machines," said Joe Camaratta, vice president of global solutions for the U.S. "Siemens is investing a lot of time looking into how to make radiologists' jobs easier in reading them."
The firm released its first CAD product three years ago, syngo LungCare CT NEV (nodule-enhanced viewing), which is in use at about 500 sites worldwide, according to Siemens. A year later, the company introduced a similar product called syngo Colonography PEV (polyp-enhanced viewing).
The products emphasize identification and localization, but the future in both lung scanning and colonography will be in more ambitious developments.
"We have been looking at how CAD might help differentiate malignant from nonmalignant lesions," Camaratta said.
The company has been working with sites running its PEV and NEV products and collecting lung and colonography cases. The data are being analyzed to address a single basic question.
"Can we do more than just detect lesions?" he asked.
Engineers have been edging both PEV and NEV toward an answer. The software already automates the comparison of subsequent exams, identifying changes in the size, location, or appearance of nodules and polyps over time.
"Physicians can easily see any changes that appear in patients coming back for regular virtual colonographies," he said.
If these products keep evolving, Siemens may be able to highlight the kinds of changes radiologists need to know when making differential diagnoses.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.